BSX Related Analyst Ratings
-
UBS Upgrades Boston Scientific (BSX) to Buy
-
Morgan Joseph Initiates Coverage on Boston Scientific (BSX) with a Hold; Shares Fully Valued
-
Wedbush Initiates Coverage on Boston Scientific (BSX) with a Neutral; Shares Fully-Valued
-
Wells Fargo Downgrades Boston Scientific (BSX) to Market Perform; Lowers EPS Estimates
-
Barclays Starts Stocks in Medical Equipment Group: EW, COV, MDT, ZMH at Overweight, SYK, BCR at Underweight
-
RBC Raises Estimates on Abbott (ABT), Lowers Estimates on Boston Scientific (BSX)
-
JMP Starts 7 Stocks in the Medical Equipment Sector: MDT, STJ, NUVA at Market Outperform
-
JMP Securities Initiates Coverage on Boston Scientific (BSX) with a Market Perform
-
Goldman Sachs Neutral on Medical Technology; COV, NUVA, ZMH Top Ideas
-
UBS Downgrades Boston Scientific (BSX) to Neutral
-
Brean Murray Upgrades CardioNet (BEAT) to Buy; Valuation Compelling Enough, Given Risk/Reward
-
BMO Capital Upgrades Boston Scientific (BSX) to Outperform
-
Lazard Starts Boston Scientific (BSX) at Hold
-
Gabelli Upgrades Boston Scientific (BSX) to Buy
-
Collins Stewart Initiates Coverage on Boston Scientific (BSX) with a Hold
-
Baird Initiates Coverage on Several Medical Instruments & Supplies Stocks
-
Barron's Article Comments on Medtronic (MDT): Shares Could Move 10 Points Higher on Positive Guidance
-
Needham & Co Reiterates a 'Buy' on Given Imaging (GIVN); Could be Attractive Acquisition Target
-
RBC Capital Initiates Coverage on Several Medical Instruments & Supplies/Drug Stocks - Abbott Labs Named Top Pick
-
Wachovia Upgrades Boston Scientific (BSX) to Outperform, Compelling Valuation on Improved Outlook in Key Markets
-
UBS Initiates Coverage on Boston Scientific (BSX) with a Buy
-
Caris Upgrades Boston Scientific (BSX) to Average
-
Boston Scientific (BSX) Sell-Off Appears Unwarranted -Piper Jaffray
-
Matrix USA Rating Changes 10/9
-
Merrill Lynch Downgrades Boston Scientific (BSX) to Underperform
-
Merrill Lynch Downgrades Boston Scientific (BSX) to Underperform
-
BofA Initiates Coverage on Boston Scientific (BSX) with a Buy
-
Morgan Stanley Assumes Coverage on Boston Scientific (BSX) with an Overweight
-
Piper Jaffray Initiates Boston Scientific (BSX) with a Buy
-
Leerink Swann Initiates Coverage on Numerous Medical Equipment Stocks
-
ARGUS Upgrades Boston Scientific (BSX) to Buy
-
Matrix USA Rating Changes 5/21
-
Citi Upgrades Boston Scientific (BSX) to Hold
-
Morgan Stanley upgrades Boston Scientific (BSX) to Overweight
-
BofA Upgrades Boston Scientific (BSX) to Buy
-
Needham Starts NuVasive (NUVA) at Buy; Says Co Is An Attractive Buyout Target
-
Credit Suisse Initiates Coverage on Medical Equipment Makers
-
Goldman Sachs downgrades Boston Scientific (BSX) to Neutral
-
USA Matrix Rating Changes 10/23
-
Needham More Positive on Given Imaging (GIVN), Sees As Possible Takeover Tgt
-
Collins Stewart upgrades Cyberonics (CYBX) to Buy
-
Thomas Weisel Initiates Coverage on Boston Scientific (BSX) with an Underweight
-
Wachovia Securities Initiates Coverage on EYE, JNJ, BSX, BOL and COO with a Market Perform
-
Sanford C Bernstein Upgrades BSX, MDT and STJ to Outperform
-
Bear Stearns downgrades Boston Scientific (BSX) to Peer Perform
-
Boston Scientific (BSX) over all implied volatility near average into FDA Advisory Panel meeting
-
Credit Suisse initiates coverage on Medical Supply Stocks with a new Underweight rating
-
FTN Midwest Downgrades Boston Scientific (BSX) to Neutral
-
Merrill Lynch downgrades Boston Scientific (BSX) to Sell
-
S&P Equity Research Downgrades Boston Scientific (BSX) to Sell
Back to BSX Stock Lookup
